NoSQL Zone is brought to you in partnership with:

Davy Suvee is the founder of Datablend. He is currently working as an IT Lead/Software Architect in the Research and Development division of a large pharmaceutical company. Required to work with big and unstructured scientific data sets, Davy gathered hands-on expertise and insights in the best practices on Big Data and NoSql. Through Datablend, Davy aims at sharing his practical experience within a broader IT environment. Davy is a DZone MVB and is not an employee of DZone and has posted 27 posts at DZone. You can read more from them at their website. View Full User Profile

Similr: blazingly fast chemical similarity searches

02.06.2013
| 2276 views |
  • submit to reddit

Today, Datablend announces Similr to be available for beta sign-up. Similr allows scientist (both from academics and enterprise) to quickly search for compounds that exhibit a particular chemical structure. It employs a wide range of fingerprinting algorithms, which combined, allow to identify matching compounds in millisecond time. Similr’s functionalities are available through a flexible and expressive REST API and allows to scan more than 30 million compounds that have been made publicly available through PubChem. Sign up for the beta right now at similar.li!

Similr will provide unlimited API-access to academics. Free commercial access, limited to a 1000 API-calls a month, will be available. Higher up, customers can choose between a pay-as-you-go subscription or opt-in for a dedicated installation that allows for the import of (private) compounds.

Similr is being developed by Datablend, a Big Data consultancy company. Datablend’s expertise in Pharma, combined with proficient knowledge of NoSQL technologies, allowed for the development of a highly optimised chemical similarity search algorithm that is able to scan millions of compounds at blazing speeds. Don’t hesitate to contact us if you have any questions related to Similr and/or Datablend.

Published at DZone with permission of Davy Suvee, author and DZone MVB. (source)

(Note: Opinions expressed in this article and its replies are the opinions of their respective authors and not those of DZone, Inc.)